Werewolf Therapeutics annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Werewolf Therapeutics Depreciation & Amortization Growth & History (HOWL)
Werewolf Therapeutics's depreciation and amortization was $1.6M for fiscal 2025.
View full Werewolf Therapeutics company overviewWerewolf Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.6M | −$180,000 | −9.92% |
| 2024 | 2024-12-31 | $1.8M | $50,000 | +2.83% |
| 2023 | 2023-12-31 | $1.8M | $660,000 | +59.78% |
| 2022 | 2022-12-31 | $1.1M | $888,000 | +411.11% |
| 2021 | 2021-12-31 | $216,000 | $66,000 | +44.00% |
| 2020 | 2020-12-31 | $150,000 | — | — |
Werewolf Therapeutics quarterly depreciation and amortization
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.5M | $2.0M | +503.94% |
| Q1 2026 | 2026-03-31 | $398,000 | −$28,000 | −6.57% |
| Q4 2025 | 2025-12-31 | $400,000 | — | — |
| Q3 2025 | 2025-09-30 | $402,000 | −$52,000 | −11.45% |
| Q2 2025 | 2025-06-30 | $406,000 | −$48,000 | −10.57% |
| Q1 2025 | 2025-03-31 | $426,000 | −$38,000 | −8.19% |
| Q3 2024 | 2024-09-30 | $454,000 | $9,000 | +2.02% |
| Q2 2024 | 2024-06-30 | $454,000 | $20,000 | +4.61% |
| Q1 2024 | 2024-03-31 | $464,000 | $39,000 | +9.18% |
| Q3 2023 | 2023-09-30 | $445,000 | $41,000 | +10.15% |
| Q2 2023 | 2023-06-30 | $434,000 | $249,000 | +134.59% |
| Q1 2023 | 2023-03-31 | $425,000 | $327,000 | +333.67% |
| Q3 2022 | 2022-09-30 | $404,000 | $337,000 | +502.99% |
| Q2 2022 | 2022-06-30 | $185,000 | $123,000 | +198.39% |
| Q1 2022 | 2022-03-31 | $98,000 | $59,000 | +151.28% |
| Q3 2021 | 2021-09-30 | $67,000 | $26,000 | +63.41% |
| Q2 2021 | 2021-06-30 | $62,000 | $20,000 | +47.62% |
| Q1 2021 | 2021-03-31 | $39,000 | $16,000 | +69.57% |
| Q3 2020 | 2020-09-30 | $41,000 | — | — |
| Q2 2020 | 2020-06-30 | $42,000 | — | — |
| Q1 2020 | 2020-03-31 | $23,000 | — | — |
Werewolf Therapeutics depreciation and amortization trends
Over the last five fiscal years, Werewolf Therapeutics's depreciation and amortization increased from $150,000 to $1.6M, a change of $1.5M. The latest reported quarter, Q2 2026, shows $2.5M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Werewolf Therapeutics source filings ↗